BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 20041967)

  • 1. Myelodysplastic syndrome in elderly patients: correlation of CBC with cytogenetic and FISH analysis.
    Codispoti KE; Depalma L
    Int J Lab Hematol; 2010 Aug; 32(4):443-8. PubMed ID: 20041967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardized fluorescence in situ hybridization testing based on an appropriate panel of probes more effectively identifies common cytogenetic abnormalities in myelodysplastic syndromes than conventional cytogenetic analysis: a multicenter prospective study of 2302 patients in China.
    Lai YY; Huang XJ; Li J; Zou P; Xu ZF; Sun H; Shao ZH; Zhou DB; Chen FP; Liu ZG; Zhu HL; Wu DP; Wang C; Zhang Y; Li Y; Hou M; Du X; Wang X; Li W; Lai YR; Zhou J; Zhou YH; Fang MY; Qiu L; Wang XM; Zhang GS; Jiang M; Liang YM; Zhang LS; Chen XQ; Bai H; Lin JY
    Leuk Res; 2015 May; 39(5):530-5. PubMed ID: 25823643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?
    Costa D; Valera S; Carrió A; Arias A; Muñoz C; Rozman M; Belkaid M; Coutinho R; Nomdedeu B; Campo E
    Leuk Res; 2010 Nov; 34(11):1437-41. PubMed ID: 20226525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Detecting chromosomal aberrations in myelodysplastic syndrome with fluorescence in situ hybridization and conventional cytogenetic analysis].
    Cao P; Li Y; Li X; Zhang G; Chen F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 39(6):605-11. PubMed ID: 25011965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal Abnormalities in Myelodysplastic Syndrome Patients in Upper Northern Thailand.
    Phrommin S; Tantiworawit A; Rattanathammethee T; Puaninta C; Pangjaidee N; Aungsuchawan S; Bumroongkit K
    Asian Pac J Cancer Prev; 2020 Mar; 21(3):639-645. PubMed ID: 32212788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of Fluorescence In Situ Hybridization Panel for Myelodysplastic Syndrome in Evaluation of Cytopenia in a Pediatric Hospital: A 5-Year Retrospective Review and Utilization Management.
    Bunting CT; Senior T; Susson Y; Rivera A; Saxe D; Bunting ST
    Lab Med; 2017 Aug; 48(3):266-270. PubMed ID: 28934515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic classification of MDS is improved by the inclusion of FISH panel testing with conventional cytogenetics.
    Kokate P; Dalvi R; Koppaka N; Mandava S
    Cancer Genet; 2017 Oct; 216-217():120-127. PubMed ID: 29025586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional and molecular cytogenetic features of myelodysplastic syndrome in China.
    Chen L; Li J; Zhu Y; Qiu H; Pan J; Wang R; Qian S; Xu W; Xue Y
    Exp Oncol; 2007 Dec; 29(4):299-303. PubMed ID: 18199987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional cytogenetics and fluorescence in situ hybridization in persistent cytopenias and myelodysplastic syndromes in childhood.
    Touliatou V; Kolialexi A; Tsangaris GT; Moschovi M; Polychronopoulou S; Mavrou A
    Anticancer Res; 2004; 24(6):3945-9. PubMed ID: 15736436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of chromosome abnormalities in myelodysplastic syndromes with interval fluorescence in situ hybridization].
    Ru X; Li Q; Fang XS; Li Y; Wang X; Zhang LY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):116-20. PubMed ID: 23484703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hidden chromosome 8 abnormalities detected by FISH in adult primary myelodysplastic syndromes.
    Panani AD; Pappa V
    In Vivo; 2005; 19(6):979-81. PubMed ID: 16277010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A comparative study of fluorescence in situ hybridization versus conventional cytogenetics in the detection of clonal aberrations in myelodysplastic syndrome].
    Lai YY; Li N; Feng L; Shi Y; Dang H; He Q; Wang Z; Wang XY; Li Y; Liu Q; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(40):3175-9. PubMed ID: 24405535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
    Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplex ligation-dependent probe amplification and fluorescence in situ hybridization for detecting chromosome abnormalities in myelodysplastic syndromes: A retrospective study.
    Ai X; Li B; Xu Z; Liu J; Qin T; Li Q; Xiao Z
    Medicine (Baltimore); 2021 May; 100(18):e25768. PubMed ID: 33950965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic aberrations in myelodysplastic syndrome detected by comparative genomic hybridization and fluorescence in situ hybridization.
    Wilkens L; Burkhardt D; Tchinda J; Büsche G; Werner M; Nolte M; Ganser A; Georgii A
    Diagn Mol Pathol; 1999 Mar; 8(1):47-53. PubMed ID: 10408793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cytogenetic characteristics of hematopoietic and stromal progenitor cells in myelodysplastic syndrome].
    Pimenova MA; Parovichnikova EN; Kokhno AV; Domracheva EV; Manakova TE; Mal'tseva IuS; Konnova ML; Shishigina LA; Savchenko VG
    Ter Arkh; 2013; 85(7):34-42. PubMed ID: 24137945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [WHO classification and cytogenetic analysis of 435 cases with myelodysplastic syndrome].
    Wang XQ;
    Zhonghua Nei Ke Za Zhi; 2008 Jun; 47(6):464-7. PubMed ID: 19040061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring of the Clonal Fraction by Fluorescence In Situ Hybridization in Myelodysplastic Syndrome: Comparison With International Working Group Treatment Response Criteria.
    Park JH; Kim M; Kong SY; Yoon SS; Lee DS
    Arch Pathol Lab Med; 2016 Jun; 140(6):560-9. PubMed ID: 27232348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization:  Defining an Effective Utilization Strategy for Evaluation of Myelodysplastic Syndromes.
    He R; Wiktor AE; Durnick DK; Kurtin PJ; Van Dyke DL; Tefferi A; Patnaik MS; Ketterling RP; Hanson CA
    Am J Clin Pathol; 2016 Jul; 146(1):86-94. PubMed ID: 27353768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cytogenetics with FISH in 40 myelodysplastic syndrome patients.
    Romeo M; Chauffaille Mde L; Silva MR; Bahia DM; Kerbauy J
    Leuk Res; 2002 Nov; 26(11):993-6. PubMed ID: 12363467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.